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ABSTRACT 
AGE-ASSOCIATED CHANGES IN INNATE IMMUNITY AND THEIR IMPACTS 
ON INFLAMMATORY DISEASES 
Mehmet Akif Eskan DDS 
November 3, 2011 
Periodontal disease arises from excessive host inflammatory responses to 
the tooth-associated microbial biofilm, known as dental plaque. Severity ranges 
from superficial inflammation of the gingivae (gingivitis) to extensive destruction 
of connective tissue and bone (periodontitis) leading to tooth loss. In its severe 
form, periodontitis affects 10 - 15% of the total human population to the extent 
that they will lose half their teeth by age 50. Periodontitis, a prevalent chronic 
disease with an impact on systemic health, such as atherosclerosis and 
Alzheimer's disease, is critically dependent on neutrophils. Although conventional 
periodontal treatment may reverse destructive inflammation, a subset of patients 
develops recurrent disease for reasons that are not clear, thus necessitating 
better understanding of the underlying immunopathology. Therefore, there is a 
compelling need to elucidate pathogenic mechanisms, which may be targeted for 
novel therapeutic intervention strategies in periodontal disease. 
Developmental endothelial locus-1 (Del-1) was recently identified as a 
novel endothelial-derived inhibitor of neutrophil extravasation. However, whether 
v 
Oel-1 regulates the local tissue-specific inflammatory response and controls 
chronic inflammatory diseases has not been addressed yet. Upon aging, normal 
mice displayed increased disease accompanied by diminished Oel-1 expression. 
Consistent with a protective role for Oel-1 in periodontitis, Del-1-1- mice developed 
spontaneous inflammatory periodontal bone loss characterized by excessive 
local neutrophil infiltration and interleukin (IL)-17 expression. The disease was 
reversed in Del-1-1- mice with additional genetic deficiencies in the LFA-1 integrin 
or the IL-17 receptor. Strikingly, local administration of Oel-1 suppressed 
neutrophil infiltration and IL-17 expression in the periodontal tissue. We, 
therefore, concluded that Oel-1 is required for tissue homeostasis by regulating 
LFA-1-dependent neutrophil trafficking, inhibiting IL-17-mediated pathology, and 
may be a promising novel therapeutic for the treatment of inflammatory diseases. 
In conclusion, we showed that Oel-1, a novel inhibitor of integrin-
dependent neutrophil adhesion, regulates local tissue-specific inflammation and 
controls chronic inflammatory disease. Oel-1 inhibits LFA-1-dependent neutrophil 
recruitment and IL-17-mediated pathology and may be a promising novel 
therapeutic for inflammatory diseases. 
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1. INTRODUCTION 
Aging and Inflammation 
The elderly population is increasing. According to the US Bureau of the 
Census, in 1997, 1 in 8 Americans were over 65 years old and it is expected that 
1 in 5 Americans will be elderly by 2030 (Figure 1). Age is usually considered as 
a risk factor for increased inflammation and impaired wound healing [1]. 
Physiological loss of periodontal attachment and alveolar bone is seen in the 
elderly and is normally of little clinical significance. However, these changes can 
become severe in the presence of concomitant periodontal inflammation as an 
individual ages [2, 3]. This is consistent with the inflammatory etiology of 
periodontal disease, where tissue damage is primarily caused by excessive host 
inflammatory reactions to subgingival gram-negative anaerobic pathogens [4]. 
Conversely, it may be argued that the increased severity of periodontitis in old 
age could be simply the cumulative effect of prolonged exposure to microbial 
challenge. While this might be a contributory factor, several observations 
support the significance of age-related alterations in the periodontal immune 
response. In an experimental gingivitis study involving young (20-25 years of 
age) and elderly (~ 65 years) individuals, all subjects received professional dental 
care to establish healthy gingival starting conditions and, subsequently, 
abstained from oral hygiene. Although young and old subjects displayed 
1 
comparable dental plaque biofilm accumulation, the latter group developed more 
severe gingivitis associated with elevated numbers of inflammatory cells [5] 
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Figure 1. The percentage of elderly is increasing in USA. This shows that the 
elderly population is increasing in USA. 
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The elderly are at increased risk for microbial infection leading to chronic 
inflammation and malignancy [6, 7]. Individuals are not equally affected by the 
accumulation of bacterial plaque around their teeth. Very susceptible subjects 
will develop aggressive forms of periodontitis at a relatively young age whereas 
others may never develop periodontitis [8]. Most of the population fall 
somewhere between these extremes. This might be explained by that monocytes 
that were carrying different human leukocyte antigen (HLA) harvested from 
different subjects. Those monocytes responded differently to LPS stimulation 
with production of pro-inflammatory cytokines, including interlukin 1, tumor 
necrosis factor alpha or prostaglandin E2, supporting a genetically determined 
basis for inflammatory disorders [9]. Shapira et al. [10] suggested that inter-
individual differences in monocyte/macrophage responses can be found in 
periodontitis patients compared to healthy subjects [10, 11]. As humans age, 
they encounter more disease and most of these diseases are due to declines of 
cellular function, affecting all cell types to different extents. Impaired wound 
healing in the elderly presents a major clinical and economic problem. With the 
aging population growing in both number and percentage, the importance of 
understanding the mechanisms underlying age-related impairments in healing 
increases. Normal periodontal tissues exhibit characteristic changes with age 
that have implications for wound healing [12]. It also has been reported that 
periodontal attachment loss and gingival recession showed an increase by age 
[13, 14]. All together, efficient cell function enhances wound healing and limits 
4 
chronic disease and any functional decline in these processes are important 
health concerns for the elderly. 
More than three decades ago, Page and Schroeder reported that 
polymorphonuclear neutrophils (PMNs) play an important role in periodontal 
disease progression [15]. It has been consistently reported that periodontally 
diseased gingiva are abundant with primed and hyperactivated neutrophils 
releasing oxygen radicals, cytokines and chemokines [16]. Neutrophils might play 
an important role during the transition from gingivitis to periodontitis. In fact, the 
concept of a primed or hyperactive neutrophil in chronic [17, 18] or aggressive 
periodontitis [19] has begun to emerge, leading to a new perspective on the role 
of neutrohils in periodontitis. They are considered scavenging phagocytes, which 
clear microbes, play a major role in the control of infections by intracellular 
pathogens and modulate the immune system [20]. In addition to neutrophils, for 
example, interleukin-17 (IL-17) has been reported to be involved in chronic 
inflammatory diseases [21,22]. 
5 
------~ 
Neutrophils and IL-17 
Recently, it has been shown that interleukin-17 (also known as IL-17A) is 
a key cytokine regulating the infiltration of neutrophils into tissues [23]. 
Specifically, IL-17A has been reported to regulate neutrophil mobilization by 
promoting granulopoiesis, [24, 25]. Moreover, IL-17 has been shown to 
orchestrates activation of neutrophils during inflammation [26, 27]. IL-17 was also 
shown to induce the activations and survival of neutrophils [26-28]. 
The interleukin-17 (IL-17) family, IL-17A to IL-17F, is emerging as major 
players in immune responses and inflammatory diseases [29]. These cytokines 
mediate their biological functions through the IL-17 receptor family, IL-17RA to 
IL-17RE [30]. 50% of the IL-17A and IL-17F structure is identical (Figure 2), 
accounting for their sharing several biological properties [30]. It has been well 
documented that several cell types, such as T cells, neutrophils, and 
macrophages, express IL-17A and IL-17F [22, 30, 31]. Tissue mediated innate 
immunity can be promoted by IL-17A and IL-17F by inducing pro-inflammatory 
responses. IL-17 target molecules include chemokines (CXCL 1, CXCL8, 
CXCL 10), cytokines (TNF-a, IL-1, IL-6, and GM-CSF) and acute/delayed-phase 
responses (RANKL) [24]. Furthermore, it has been reported that the combined 
action of IL-17A or IL-17F with other cytokines including, TNF-a, IL-1~ and IFN-y 
synergistically augments the induction of pro-inflammatory responses [32, 33]. 
Consistently, I L-17 A has been implicated in bone resorption in mouse models of 
arthritis [34] and the absence of IL-17A expression reduced disease activity in 
rheumatoid arthritis [22, 35]. Parallel to these studies, neutrophils and IL-17A 
6 
interaction has been reported to induce myocarditis and/or myocardial infarction 
following experimental bacteremia of Porphyromonas gingiva/is in mice [36]. 
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Figure 2. Homology of IL-17 family members to IL-17 A. This diagram shows the 
percentage homology between IL-17A and each of the IL-17 family members. IL-
17A shares greater homology with IL-17F, while other family members are more 
divergent. Percentages reflect both human and mouse IL-17 family members. 
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Del-1 and Neutrophils 
In response to tissue infection, leukocytes extravasate into peripheral 
tissues and attempt to kill pathogenic microorganisms. In this regard, and in the 
context of periodontitis, PMNs form a first line of defense and promptly migrate to 
the gingival crevice in response to the tooth-associated pathogenic biofilm [37]. 
PMNs attempt to kill the invading microbes by releasing the toxic contents of their 
granules including reactive oxygen species (ROS) and reactive nitrogen species, 
proteinase 3, cathepsin-G and elastase [38]. These highly potent effectors do not 
discriminate between microbial and host cells, and may result in collateral 
damage to the host tissues [39]. Because neutrophils display a large array of 
microbicidal and proinflammatory mechanisms that are potentially harmful to the 
host, their activation and trafficking is tightly regulated [40-43]. Therefore, tight 
regulation of PMN recruitment is important for preventing excessive influx and 
unwarranted inflammation. Inflammatory cell recruitment happens in the three 
steps involving rolling, activation and adhesion [44]. PMN recruitment to inflamed 
tissue is regulated by selectins that facilitate cell rolling and activation of 132 
integrins (CD11/CD18) which in turn mediate stable adhesion and migration 
across the blood vessel [45]. A transition from rolling to arrest involves a shift in 
132 integrins from a low- to high-affinity state which allows it to bind intracellular 
adhesion molecule-1 (ICAM-1) on endothelial cells (Figure 3) [46]. Following the 
arresting step, the leukocyte function associated antigen-1 (LFA-1, also known 
as aL132 or CD11a/CD18) [47, 48] plays a critical role for the neutrophil migration 
into injured tissue [49]. ICAM-1 can adhere with ringlike cluster of LFA-1 cluster 
9 
during neutrophil transmigration [44]. Therefore, the neutrophil transmigration 
across inflamed endothelium is controlled through LFA-1 interactions with ICAM-
1 [49, 50]. In addition to these molecules, Table 1 shows some other molecules 
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Figure 3. Neutrophil transmigration through endothelial cells. P-selectins 
playa major role to capture neutrophils , whereas ICAM-1 plays a critical role for 
their transmigration . After the neutrophils phagocytose microorganisms and 
degranulate, they may either undergo apoptosis or necrosis. Uptake of apoptotic 
neutrophils by macrophages downmodulates the production of IL-23, leading to 
downregulation of IL-17 production . 
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Gene Function Ref 
Ly6G Defines neutrophils [51] 
ICAM-1 Plays a critical role in the neutrophil recruitment [48,49] 
LFA-1 
(CD11a/ldgal) Plays a critical role in the neutrophil recruitment [48,49] 
Inhibits LFA-1-ICAM-1 interactions and limits neutrophil migration to sites 
Del-1 of infection/inflammation [52] 
CD62E Increases LFA-1 affinity to ICAM-1 [53] 
KC (CXCL 1) Involved in neutrophil chemotaxis [54,55] 
Chemokine produced by neutrophils; induces Th17 migration to sites of [56, 57],[ 
CCL2 inflammation 58] 
Chemokine produced by neutrophils; induces Th17 migration to sites of 
CCL20 inflammation [58-61] 
[57, 58, 
CCR2 Chemokine receptor (responds to CCL2); mediates Th17 recruitment 62] 
[57, 58, 
CCR6 Chemokine receptor (responds to CCL20); mediates Th17 recruitment 61,63] 
Transcription factor; required for Th17 cell differentiation; defines Th17 
RORyt cells [64] 
IL-6 Promotes Th17 cell differentiation [65] 
TGF-j3 Promotes Th17 cell differentiation [65] 
IL-21 Produced by Th17; induces and amplifies Th17 in cooperation with TGF-j3 [66] 
IL-22 Produced by Th17 cells in response to IL-23 [67] 
IL-23 Stabilizes the commitment of developing Th17 cells to the Th17 lineage [65,68] 
IL-17A Control of extracellular pathogens, induction of matrix destruction [69,70] 
TNF-a Major effector of periodontal bone loss [71] 
IL-1j3 Major effector of periodontal bone loss [71] 
Table 1. Some other important molecules that play important role in neutrophil 
and IL-17 mediated tissue destruction. 
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Since circulating neutrophils readily migrate to sites of extravascular 
infection or inflammation to eliminate or control pathogenic insults, the 
extravasation of neutrophils is critically dependent on a series of well-coordinated 
adhesive events, as we discussed above, including the interactions of integrins of 
the 132 or 131 family with endothelial countereceptors of the Ig superfamily [40, 
43]. In contrast to multiple factors promoting leukocyte extravasation, little 
is known about inhibitors of the leukocyte adhesion cascade. In this context, a 
52-kDa glycoprotein, known as developmental endothelial locus-1 (Del-1), was 
recently identified as a novel negative regulator of neutrophil extravasation acting 
by antagonizing the interaction between ICAM-1 and LFA-1 (Figure 4) [52]. It 
also has been shown that Del-1 induced engulfment of apoptotic cells [72]. 
Pentraxin 3 (PTX3) is another recently identified inhibitor of neutrophil 
extravasation, which acts by suppressing selectin-dependent rolling [73]. In 
contrast to PTX3, however, Del-1 is produced by the tissue rather than the 
inflammatory cell itself [52, 73]. Specifically, Del-1 is secreted by endothelial cells 
and may associate with the endothelial cell surface and the extracellular matrix 
[43, 62]. This observation predicts that Del-1 could play a critical role in 
regulating the local chronic inflammatory response in tissues expressing it; 




Figure 4. The interaction between Del-1 and LFA-1. Del-1 inhibits the 
interaction between ICAM-1 and LFA-1 by binding CD11 a. 
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We reasoned that Oel-1 may provide a mechanism whereby a tissue itself 
may control or prevent persistent inflammation associated with chronic 
recruitment of neutrophils. As we discussed above, periodontitis is a chronic 
inflammatory disease and neutrophils modulate its progression [15]. Therefore, 
periodontitis represents an attractive model to determine the role of Oel-1 in 
neutrophil-mediated chronic inflammation with impact on systemic diseases. Old 
age and age-associated inflammation are factors that contribute to increased 
prevalence and severity of periodontitis in humans and mice [74, 75]. Our 
overall hypothesis is that age-associated reductions in Oel-1 expression 
leads to excessive recruitment of neutrophils and increased IL-17 A 
production in periodontal tissues, resulting in enhanced periodontal 
inflammation and periodontal bone loss. (Figure 5). This hypothesis 
constitutes a novel mechanism for the increased periodontal tissue destruction 
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Figure 5. Our hypothesis. Uncontrolled neutrophil accumulation due to reduced 
Del-1 expression results in increased IL-17, leading to chronic inflammation. 
16 
Significance: Our proposed experiments are expected to reveal novel 
mechanisms of periodontal pathogenesis and pave the way for Del-1-based 
therapeutic intervention in periodontitis. On the basis of our hypothesis that Del-
1 expression decreases with aging, Del-1-based therapy could be extremely 
beneficial to elderly patients who run a higher risk for periodontitis [5]. Del-1-
based control of periodontal disease can also decrease the risk for systemic 
inflammatory diseases, like atherosclerotic heart disease, which is 
epidemiologically and mechanistically linked to periodontitis [37, 76, 77]. 
17 
2. MATERIALS AND METHODS 
Mice. All mice used were on C57BLl6 background. IL-17RA'- and LFA-r'-
mice were generously provided, respectively, by Amgen (Seattle, WA)[78] and 
Dr. C.M. Ballantyne (Baylor College of Medicine) [79]. The generation of Oel-r'-
and Oel-r'--LFA-r'- mice was previously described [52]. In this study, the Oel-r'-
and IL-17RA'- mice were crossed to generate double knock-outs (Oel-r'--IL-
17RA'-). Old C57BLl6 mice (18 months of age) were obtained from the National 
Institute of Aging. In aging experiments to investigate the effect of Del-1 
deficiency, knockout mice and wild-type littermate controls were reared in parallel 
under specific-pathogen-free conditions in individually ventilated cages in the 
Barrier Animal Facility of the University of Louisville. All animal procedures 
described in this study were approved by the Institutional Animal Care and Use 
Committee, in compliance with established federal and state policies. 
Determination of periodontal bone loss. Periodontal bone levels were 
assessed in defleshed maxillae under a dissecting microscope (x40) fitted with a 
video image marker measurement system (VIA-170K; Boeckeler Instruments) 
standardized for measurements in millimeters. Specifically, the distance from the 
cementoenamel junction (CEJ) to the alveolar bone crest (ABC) was measured 
on 14 predetermined points on the buccal surfaces of the maxillary molars [80, 
81]. To calculate relative bone loss (e.g., Oel-r'- mice vs. wild-type controls, or 
18 
old mice vs. young controls}, the 14-site total CEJ-ABC distance for each mouse 
was subtracted from the mean CEJ-ABC distance of control mice. The results 
were expressed in mm and negative values indicated bone loss relative to 
controls [80, 81]. In certain experiments, bone loss was measured in mice which 
were administered antibiotics in their drinking water (sulfamethoxazole and 
trimethoprim at a final concentration of 800 j..Ig/ml and 400 j..Ig/ml, respectively). 
Oral bacterial sampling. To assess the oral microbial burden, the murine 
oral cavity was sampled for 15 seconds using sterile paperpoints held against the 
gumlines [81]. Serial dilutions of the paperpoint extracts were plated onto blood 
agar plates for anaerobic growth and CFU determination. 
Quantitative real-time peR. Gingival tissue was excised from around 
the maxillary molars. Total RNA was extracted by using the PerfectPure RNA cell 
kit (5 Prime, Fisher) and quantified by spectrometry at 260 and 280 nm. The 
RNA was reverse-transcribed using the High-Capacity cDNA Archive kit (Applied 
Biosystems) and quantitative real-time PCR with cDNA was performed using the 
ABI 7500 Fast System, according to the manufacturer's protocol (Applied 
Biosystems). TaqMan probes, sense primers, and antisense primers for 
expression of genes examined in this study (Figures 13 and Table 2), or a house-
keeping gene (GAPDH), were purchased from Applied Biosystems. 
Immunohistochemistry. Upper jaws (maxillae) with intact surrounding 
tissue were fixed in 4% paraformaldehyde, decalcified in Immunocal Solution 
(Decal Chemical Corp.) for 15 days, and embedded in OCT compound. Serial 
19 
mesio-distal sections (7- to 8-lJm thick) parallel to the long axis of the teeth 
(sagittal) were stained with antibodies to human/mouse Del-1 (Proteintech), 
mouse Ly6G, a specific neutrophil marker [51] (FITC-conjugate; lifeSpan 
BioSciences), human/mouse IL-17 A (Santa Cruz Biotech), and human/mouse 
TNFa (Abcam). The antibodies to Del-1, IL-17A, and TNFa were rabbit IgG and 
staining involved the use of a secondary reagent (Texas red-goat anti-rabbit IgG; 
Molecular Probes). The specificity of staining was confirmed by using FITC-
conjugated isotype control (rat IgG2b) or normal rabbit IgG followed by Texas 
red-conjugated goat anti-Rabbit IgG. Images were captured using a laser-
scanning confocal microscope (Olympus FV1000). Fluorescence intensity was 
quantified using the Image J software (NIH; http://rsb.info.nih.gov/ij). 
Human samples. Under IRB approval, samples were collected from 
patients undergoing periodontal surgery at the graduate periodontics clinic. 
Diseased tissues were usually collected around involved tooth. Healthy tissues 
were usually collected from the distal of last molar teeth in maxilla. Diseased 
sites were determined if attachment loss was more than 5 mm and/or bleeding 
on probing. Excised tissues, nature of periodontal surgery, kept on 10% of 
formalin for future staining of Del-1 and/or IL-17A. Gingival tissue samples were 
incubated with 10% paraformaldehyde at 4°C and washed with 5%, 10%, and 
15% glycerol for 15 minutes. The tissues were immersed in 30% sucrose for 30 
min and embedded in a medium for frozen tissues (Tissue-Tek) for cryostat 
sectioning (10 IJm). Samples were blocked with 10% BSA (Millipore) at room 
temperature for 1 hour, incubated with anti-mouse/human Del-1 (1/100, 
20 
Proteintech) or IL-17A (1/100 Santa Cruz) overnight at 4°C. Following washing 
three times with cold PBS, samples were stained with Texas red conjugated anti-
rabbit IgG (1/1000, Invitrogen) or FITC-conjugated donkey anti-goat IgG (1/200, 
Santa Cruz) for 1 hour at room temperature. The sections were mounted (Vector) 
after washing three times with cold PBS. Subsequently, pictures of the stained 
tissue sections were captured using a Confocal microscope (Olympus, V500). 
Intervention experiments. Ten 18-month-old C5BLl6 mice were 
microinjected in the gingiva with soluble recombinant mouse Oel-1 (kindly 
provided by Valentis, Inc.) [52] and another ten mice with BSA control. 
Specifically, Oel-1 or BSA (1 I-Ig in 1-1-11 volume) were microinjected through a 
28.5-gauge MicroFine needle (BO) into the palatal gingiva between the first and 
the second molar teeth, on both sides of the maxilla (Figure 6). Half of the Oel-1-
or BSA-treated mice were additionally orally inoculated with P. gingiva lis ATCC 
33277 (109 CFU) in 2% carboxymethylcellulose vehicle and the other half were 
orally given vehicle only. To determine whether IL-17 regulates Oel-1 expression 
in old mice, a neutralizing anti-IL~17 mAb (clone M210, rat IgG2a, kindly provided 
by Amgen) or 11-1g of azide-free rat IgG2a (Biolegend), served as a control, were 
microinjected into interdental papilla between 1 sl and 2nd molar from palatal side. 
All mice were sacrificed 12 h later. Maxillae were harvested and one side was 
stored in 4% paraformaldehyde (for immunohistochemistry; see above) while the 
other side was used to dissect interdental gingiva (between first and second 
molar teeth), which were placed into RNA-later solution (Ambion) for quantitative 






Figure 6. Del-1 intervention assay. Oel-1-Fc (1 1-11 of a 10l-lg/ml solution) was 
administered through microinjection (using a 2B .5-gauge MicroFine needle; BO) 
into the palatal gingivae between the first and the second molar, one hour prior to 
each infection. Control mice were microinjected a similar concentration of bovine 
serum albumin (BSA). This study, therefore , involved four groups of aged mice 
(5 animals per group): Sham-infected treated with BSA, Sham-infected treated 
with Oel-1-Fc, P. gingiva/is-infected treated with BSA, P. gingiva/is-infected 
treated with Oel-1-Fc. Experimental and control aged mice (5 per group) were 
microinjected with Oel-1-Fc and BSA, respectively , a total of three times every 
other day. Following each administration of Oel-1-Fc or BSA, the mice were also 
orally infected with 109 CFU P. gingiva/is 33277 in 2% carboxymethylcellulose. 
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To determine if IL-17 regulates Del-1 expression in old mice, a neutralizing anti-
IL-17 mAb was microinjected using the method as described above. The mice 
were euthanized 12h after the last infection. 
Statistical analysis. Data were evaluated by analysis of variance and the 
Dunnett multiple-comparison test using the InStat program (GraphPad Software, 
San Diego, CA). Where appropriate (comparison of two groups only), two-tailed t 
tests were performed. p < 0.05 was considered to be significant. All experiments 
were performed at least twice for verification. 
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3. RESULTS 
Aged mice show decreased Del-1 expression which correlates with 
increased bone loss. 
Old age is associated with increased susceptibility to chronic inflammatory 
diseases [2, 82-84] several of which, including periodontitis, involve neutrophil-
mediated tissue injury [12, 16, 42, 85-87]. However, none of these diseases have 
been linked to age-associated alterations in Del-1 expression, which could be 
responsible for dysregulated chronic recruitment of neutrophils to affected 
tissues. Aging mice, like aging humans, can naturally develop periodontal bone 
loss [74, 84]. We therefore examined whether age-related mouse periodontitis is 
associated with changes in Del-1 expression. Given that Del-1 is expressed in 
select tissues (e.g., brain and lungs but not liver or spleen) [43], we first 
examined and showed that Del-1 is expressed in the gingival tissue of the 
periodontium at the mRNA and protein level (Figure 7). Similar to previous 
findings in BALB/c mice [74], C57BLl6 mice (used throughout this study) 
developed periodontal bone loss in advanced age (Figure 8b). Intriguingly, 
gingival tissue harvested from 18-month-old mice displayed about 4-fold lower 
expression of Del-1 mRNA than gingiva from young mice (8- to 10-week old) 
(Figure 9b) and a pronounced difference was also noted at the protein level 
(Figure 9a, upper row). Interestingly, the reduced expression of Del-1 in the 
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gingiva of old mice was associated with higher neutrophil infiltration relative to 
young mice (Figure ga, lower row). Moreover, we found that periodontal tissue 
harvested from old mice (>18 months) exhibited about 3-fold more expression of 
IL-17 than periodontium from young mice (Figure 10). 
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Figure 7. Del-1 is expressed in the mouse gingiva. (a) Brains, livers, and 
gingiva were harvested from 8-week-old C57BLl6 mice and processed for 
quantitative real-time PCR to determine Oel-1 mRNA levels (normalized against 
GAPOH mRNA; data are means ± SO, n = 3 mice per group) . (b) Brains, livers, 
and gingiva were stained for Oel-1 protein . Brain and liver served as positive and 
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Figure 8. Reduced expression of Del-1 in old mice correlates with 
periodontal bone loss. (a) Increased bone loss in old C57BLl6 mice (18 months 
of age) compared to young controls (8-10 weeks), calculated based on measured 
distances between the cementoenamel junction (CEJ) and the alveolar bone 
crest (ABC). (b) Gingiva were dissected from the same mice and qPCR was used 
to determine Del-1 mRNA expression levels (normalized against GAPDH mRNA 
and expressed as fold change of old relative to young mice, the average value of 
which was taken as 1. Data are means ± SO; n=5 mice per group) . **p<0.01 
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Figure 9. Reduced expression of Del-1 in old mice correlates with increased 
number of neutrophils. (a) Sagittal sections of interdental gingiva of young 
(C57BLl6 , 20 weeks) and old mice (C57BLl6, 18 months of age) were stained for 
Oel-1 protein (upper left) and the neutrophil-specific marker Ly6G (lower left) ; 
shown are representative overlays of differential interference contrast and 
fluorescent confocal images (scale bar, 50lJm; T, tooth ; G, gingiva ; S, sulcus) . (b) 
The fluorescence intensities of shown image (a) and of additional representative 
images from independent mice were quantified using ImageJ analysis (data are 









Figure 10. IL-17 expression is increased in old mice. (a) Sagittal sections of 
interdental gingiva of young and old mice were stained for IL-17. (b) 
Fluorescence intensity was quantified using ImageJ analysis. Data are means ± 
SO (n=4 ; mice per group) . This experiment was repeated three times. 
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Figure 8a shows the individual values for the measured distances between the 
cementoenamel junction (CEJ) and the alveolar bone crest (ABC), which were 
used to calculate the relative bone loss in old mice (Figure 8b). Linear-regression 
analysis of the CEJ-ABC values versus Del-1 expression (data from figures 1a 
and 1 b, respectively) revealed a significant inverse association between Del-1 
expression and periodontal bone loss in old mice (Figure 11 a) (~ = 0.6254, P = 
0.0065). This association was also significant, but not as strong, within the 
young group (~ = 0.4641, P = 0.0301; Figure 11 b). Thus, an inverse relationship 
between Del-1 expression and bone loss exists not only between young and old 
mice (Figure 8b and c), but also within the individual age groups. These data 
suggest that aging is associated with Del-1 deficiency in the periodontium which 
may contribute to dysregulated neutrophil recruitment and induction of bone loss. 
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Figure 11. Reduced expression of Del-1 in old mice correlates with 
periodontal bone loss. Linear-regression analysis of the CEJ-ABC distance 
values versus Del-1 expression in old (a) and young (b) mice using the data from 
figure 9a and b. (n=5 mice per group). 
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Del-1"'- mice exhibit enhanced inflammation and bone loss 
To determine a direct role for Del-1 in preventing local inflammatory 
pathology, we investigated the periodontal phenotype of Del-1-1- mice. Sixteen-
week-old Oel-1-1- mice of either gender exhibited significant periodontal bone loss 
relative to their respective age-matched wild-type controls (Figure 12a). Female 
and male Oel-r'- mice had similar susceptibility to periodontitis, and further 
studies utilized exclusively females. To exclude the possibility that the observed 
bone loss in 16-week-old Oel-r'- mice relative to age-matched wild-type controls 
(Figure 12a) was due to innately different periodontal bone levels, we examined 
Oel-r'- and wild-type mice at different ages. At the age of 5 weeks, no difference 
in the bone levels between Oel-r'- and wild-type mice was observed, whereas 
progressive differences were seen with advancing age (Figure 12b). Therefore, 
the bone loss exhibited by Oel-r'- mice is an acquired rather than an innate trait. 
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Figure 12. Del-1 deficiency is associated with inflammatory bone loss. (a) 
Sixteen-week-old C57BLl6 wild-type (WT) or Oel-r'- mice, of either gender, were 
assessed for periodontal bone levels. (b) Periodontal bone levels in female mice 
of the indicated ages. Negative values indicate bone loss relative to WT controls 
serving as the baseline. Data are means ± SO (a & b, n=4 ; mice per group) . 
*p<O .05 ; **p<O.01 compared to corresponding control. 
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Analysis of the periodontal inflammatory response by real-time 
quantitative PCR (qPCR) showed significant differences between 16-week-old 
Oel-1-1- and age-matched wild-type mice, characterized by >6-fold elevated 
expression of IL-17A upon Oel-1 deficiency (Figure 13); this difference was 
confirmed at the protein level by immunohistochemistry (Figure 14a). A less 
pronounced but statistically significant increase was observed in the transcript 
levels of other inflammatory mediators, such as proinflammatory and bone-
resorptive molecules (TNF, IL-6, RANKL), chemokines (CCL2, CCL20), 
chemokine receptors (CCR2, CCR6), receptors that amplify inflammation (C3aR, 
C5aR, TREM-1), and costimulatory molecules (C040, COB6) (Figure 13). 
Importantly, the increased inflammation and bone loss in Oel-rl- mice was 
associated with increased infiltration of neutrophils in the gingiva (Figure 14b-c), 
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Figure 13. Del-1 deficiency is associated with inflammatory response in the 
periodontium. Sixteen-week-old C57BLl6 wild-type (WT) or De/-rl- mice, of 
either gender, were assessed for inflammatory response . Gingiva were dissected 
from 16-week-old WT or De/-rl- mice and gingival mRNA levels of the indicated 
molecules were determined by qPCR (normalized against GAPDH mRNA and 
expressed as fold change in De/-1-1- transcript levels relative to WT , the average 
value of which was taken as 1. Data are means ± SO (n=4 ; mice per group). 
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Figure 14. Increased recruitment of neutrophils and expression of IL-17 in 
the gingiva of Del-1-1- mice. (a) Sagittal sections of maxillary teeth from 16-
week-old WT or Oe/- r '- mice were stained for IL-17A (upper left) or the 
neutrophil marker Ly6G (upper right) . Shown are representative fluorescent 
confocal images (left) and corresponding differential interference contrast images 
(right) . T, tooth ; G, gingiva; S, sulcus. (b) The fluorescence intensities of images 
shown above (corresponding to IL-17 expression and neutrophil recruitment in 
the gingiva, respectively) and of additional representative images from 
independent 16-week-old wild-type (WT) and Oe/-r'- mice were quantified using 
ImageJ analysis. Data are means ± SO (n = 5 mice per group). **p < 0.01 
compared to young control. 
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Although it is the host inflammatory response that primarily can inflict 
damage upon the periodontal tissue, anaerobic oral bacteria are involved in the 
initiation and progression of periodontitis [4, 16, 88]. In this regard, Oel-r'- and 
wild-type mice initially harbored comparable levels of oral anaerobic bacteria; 
however, from the age of 8 weeks onward, Oel-r'- mice exhibited a Significantly 
higher bacterial burden relative to age-matched wild-type controls (Figure 15a). 
The development of periodontal bone loss in Oel- r l- mice was prevented by oral 
antibiotic treatment (Figure 15b), confirming the role of bacteria in this bone loss 
model, as in human periodontitis [88]. In summary, the periodontal tissue of Oel-
rl - mice displays unregulated neutrophil infiltration, elevated bacterial burden, 
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Figure 15. Del-1 deficiency is associated with elevated numbers of bacteria 
in the periodontium . (a) Wild type (WT) and Oe/-r'- mice at the indicated ages 
were assessed for oral anaerobic bacteria (CFU shown for each mouse with 
horizontal lines denoting mean values) . (b) Oe/-r '- mice were given antibiotics in 
the drinking water upon weaning (plain water served as control) and at 14 weeks 
were assessed for bone loss relative to 5-week-old Oe/-r '- mice. Data are 




Inflammatory bone loss in Del-1 deficiency requires LFA-1 function and IL-
17R signaling 
Since Del-1 acts as an antagonist of LFA-1 integrin-dependent neutrophil 
adhesion [52], we next addressed whether the bone loss seen in Oel-r'- mice 
could be attributed to increased LFA-1-mediated inflammatory cell recruitment. 
To this end, we examined the phenotype of mice with combined Del-1 and LFA-1 
deficiency (Oel-r'--LFA-r'l We found that the periodontal bone loss associated 
with Del-1 deficiency was drastically (>75%) reversed in Oel-r'--LFA-r'- mice 
(Figure 16a), which additionally displayed reduced neutrophil infiltration in the 
gingiva as compared to Oel-r'- mice (Figure 16b and Figure 17b). Therefore, the 
protective role of Del-1 against periodontitis may be mediated through regulation 
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Figure 16. Increased bone loss and neutrophil number in Del-1-1- is reversed 
in mice with dual Del-lILFA-1 deficiency. (a) Twenty-week-old C57BLl6 wild-
type (WT) mice or mice genetically deficient in the indicated molecules were 
assessed for periodontal bone levels. (b) Sagittal sections of interdental gingiva 
from the same mice were stained for the neutrophil marker Ly6G; shown are 
representative overlays of differential interference contrast and fluorescent 
confocal images. Data are means ± SO (a & b, n=5; mice per group). **p < 0.01 
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Figure 17. Del-1 deficiency-associated inflammatory response is reversed 
in mice with dual Del-1/LFA-1 deficiency. (a) Twenty-week-old Del-1 -1- or Del-
1-1- / LFA-1 -1- mice were sacrificed to detect the indicated molecules including I L-
17 and Ly6G. Sections of interdental gingiva from the indicated mice were 
stained for IL-17 (left) and Ly6G (middle) with colocalization shown in merged 
images (right) ; the bottom row includes magnified views of the demarcated areas 
just above. (b) The fluorescence intensities of the images shown here and of 
additional representative images from independent mice were quantified using 
ImageJ analysis . Data are means ± SO (a and b, n=5 ; mice per group) . **p < 
0.01 compared to indicated control. Scale bars represent 50lJm. 
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Moreover, in comparison to Oe/-r'- mice, the Oe/-r'--LFA-r'- mice 
displayed decreased gingival levels of IL-17 (Figure 17a and b) due to, at least in 
part, reduced infiltration of neutrophils which expressed IL-17. In this regard, we 
observed colocalization of IL-17 and Ly6G (specific neutrophil marker) in gingival 
tissues of both Oe/-r'- and Oe/-r'--LFA-r'-mice by immunohistochemistry 
(Figure 17a). This observation is consistent with the notion that much of the IL-17 
released at sites of inflammation derives from innate immune cells, including 
neutrophils [89]. 
As Oel-r'- mice had high IL-17 levels relative to both WT and Oel-r'--LFA-
r'- mice, we then sought to address the precise role of IL-17 in the observed 
bone loss due to Del-1-deficiency. Predicting the role of IL-17 in disease-
whether protective or destructive- is often uncertain, since IL-17 can mediate 
both antimicrobial host defenses and immunopathology [4, 22]. To conclusively 
address the role of IL-17, we generated mice with combined Del-1 and IL-17 
receptor (IL-17R) deficiency. Oel- r'--IL-17F?'- mice were completely protected 
against bone loss and were essentially indistinguishable from wild-type or IL-17R-
,- mice (Figure 18a and Figure 19), suggesting that IL-17R signaling is required 
for induction of periodontal bone loss associated with Del-1 deficiency. The 
same experiment confirmed that Oel-r'--LFA-r'- mice are protected against 
periodontitis, whereas LFA-rl- mice developed significant bone loss relative to 
wild-type mice (Figure 18a), suggesting that normal neutrophil trafficking (as 
opposed to excessive in the absence of Del-1 regulation) may mediate 
protection. All six genotypes used in these experiments had comparable bone 
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levels in early age (5 weeks) (Figure 20), ruling out an innate etiology for the 
bone loss differences seen amongst the distinct mutant mice (Figure 18a). In 
addition, the increased load of oral anaerobic bacteria due to Del-1 deficiency 
(Figure 15a) was significantly reversed in both Oel-rl--LFA-rl- and Oel-rl--IL-
17R-1- mice (Figure 18b). 
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Figure 18. Del-1 deficiency-associated inflammatory bone loss is reversed 
in mice with dual Del-1/LFA-1 or Del-1I1L-17R deficiencies. (a) Twenty-week-
old C57BLl6 wild-type (WT) mice or mice genetically deficient were assessed for 
periodontal bone levels. (b) CFU are shown for each mouse with horizontal lines 
denoting mean values. In a, negative values indicate bone loss relative to 
baseline bone levels of WT mice. Data are means ± SD (a, n=5; b, n=9-11 mice 










Figure 19. Del-1 deficiency-associated bone loss is reversed in mice with 
dual Del-1/LFA-1 or Del-111L-17R deficiencies . Representative images of 
maxillae (upper jaws) from the bone loss measurement experiment shown 
above. The bone gap [distance from the alveolar bone crest to the 
cementoenamel junction (a)] is greatest in the Oel-rl- mice, whereas mice with 
combined deficiencies (Oel-rl--LFA-1-1- or Oel-rl--IL-17R"1-) have bone levels 
comparable to those of wild-type (WT) mice (b) . See above for quantitative 
results. 
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Figure 20. Bone loss in different genotype comparable periodontal bone 
levels in early-age mice regardless of genotype. Five-week-old C57BLl6 wild-
type (WT) mice or mice genetically deficient in the indicated molecules were 
assessed for periodontal bone levels. The mm distance from the cementoenamel 
junction (CEJ) to the alveolar bone crest (ABC) was measured at 14 
predetermined sites in defleshed maxillae and was totaled for each mouse. (a) 
Data are shown for each mouse and horizontal lines indicate the mean value . (b) 
The data from panel 'a' were transformed to directly indicate bone level 
differences relative to the wild-type mice which served as the baseline. No 
significant differences were found among the groups (n = 6 to 8 mice per group) . 
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These findings indicate that Del-1 deficiency causes periodontal bone loss 
that is dependent on LFA-1-dependent neutrophil recruitment and IL-17R 
signaling. Moreover, conditions that restore tissue homeostasis in terms of 
periodontal bone maintenance (i.e., dual Del-1/LFA-1 or Del-1/IL-17R 
deficiencies) also reverse the numbers of oral bacteria to near normal levels. 
IL-17 regulates Del-1 expression as a function of age 
As IL-17 can orchestrate the production, chemotactic recruitment, and 
activation of neutrophils during inflammation [26, 27], we next examined whether 
IL-17 can additionally regulate Del-1 expression. To this end, we found that IL-
17R"'- mice exhibited increased gingival Del-1 expression relative to Wild-type 
controls (Figure 21, A-C). Consistent with the possibility that IL-17 downregulates 
Del-1 expression, local microinjection 1 f.!g of a neutralizing monoclonal antibody 
to IL-17 (clone M170) into the gingiva of old mice resulted in significant 
upregulation of Del-1 expression, whereas an isotype control had no effect 
(Figure 21 D). Furthermore, the gingival expression of IL-17 was enhanced in old 
age (Figure 21 E), in stark contrast to the decreased Del-1 expression in old mice 
(Figure B8). Moreover, linear-regression analysis of Del-1 expression versus IL-
17 expression (data from figures 18 and 4D, respectively, involving same set of 
1B-month-old mice) revealed a significant inverse association between IL-17 and 
Del-1 (r2 = 0.6274, P = 0.0063; (Figure 21 F). Taken together, the Figure 4 data 
demonstrate that Del-1 expression in the periodontal tissue is regulated by IL-17 
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Figure 21. Del-1 expression is downregulated by IL-17 in old SPF mice. (a) 
Gingival Oel-1 mRNA expression levels in wild-type (WT) and IL-17R-/- mice 
determined by qPCR (normalized against GAPOH mRNA and expressed as fold 
change relative to WT, the average value of which was taken as 1). Results are 
shown for each individual mouse. (b) Sagittal sections of interdental gingiva of 
WT and IL-17R-/- mice were stained for Oel-1 protein; shown are representative 
fluorescent confocal images (upper row) and their overlays with corresponding 
differential interference contrast images overlays (lower row). Scale bar, 501Jm; 
T, tooth; G, gingiva; S, sulcus. (c) The fluorescence intensities of the images 
shown here in B and of additional representative images from independent mice 
were quantified using ImageJ analysis (data are means ± SO; n=5 mice per 
group) (d) Anti-IL-17 mAb (M210) and IgG2a isotype control were microinjected 
into the palatal gingiva and qPCR was used to determine gingival Oel-1 mRNA 
expression. (e) GingivallL-17 mRNA expression was determined in young (8-10-
week old) and old (18 months of age) mice using qPCR. (f) Linear-regression 
analysis of the Oel-1 expression versus IL-17 expression in old mice. **p < 0.01 
compared to untreated, WT, or young controls. 
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Local administration of soluble Del-1 reverses periodontal inflammation in 
old mice. 
We next determined whether recombinantly expressed soluble Del-1 could 
be exploited therapeutically to reverse periodontal inflammation in old mice, 
which express relatively low levels of Del-1 (Figure 8 and Figure 9). Indeed, local 
gingival microinjection of soluble Del-1 resulted in reduced neutrophil infiltration 
(Figure 22a) and diminished expression of IL-17 (Figure 22b) and TNFa (Figure 
22c) in the periodontium compared to similar treatment with BSA control (Figure 
22d). Notably, Del-1 treatment of old mice suppressed both constitutive (naturally 
occurring) inflammation (Figure 22a, b, c; upper rows) as well as inflammation 
induced by exogenous oral inoculation with the human pathogen Porphyromonas 
gingivalis (Figure 22a, b, c; lower rows). The ability of soluble Del-1 to reduce 
expression of IL-17 and TNFa protein was confirmed at the mRNA level by qPCR 
which additionally revealed reduced transcript levels of a number of other 
inflammatory mediators (such as proinflammatory cytokines, chemokines, 
chemokine receptors, pattern-recognition and complement receptors, and 
costimulatory molecules; (Table 2). These data provide proof-of-concept 
evidence that Del-1 has therapeutic potential for the treatment of periodontal 
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Figure 22. Del-1 treatment reverses periodontal inflammation in old mice. 
Eighteen-month old C57BLl6 mice were microinjected in the gingiva with BSA 
(control) or Oel-1 , as indicated. In addition, the mice were orally administered P. 
gingiva/is in 2% carboxy-methylcellulose vehicle (a, b, c; lower rows) or vehicle 
control (a, b, c; upper rows) and were sacrificed 12h later. Sagittal sections of 
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interdental gingiva were stained for the neutrophil marker Ly6G (a), IL-17 A (b), or 
TNFa (c). Shown are typical fluorescent confocal images (left) and their overlays 
with corresponding differential interference contrast images (right). (d). The 
fluorescence intensities of the images shown here and of additional 
representative images from independent mice were quantified using ImageJ 
analysis; data were expressed as % intensity of the Del-1-treated groups relative 
to the BSA-treated controls, the value of which was set to 100% ('Induced 
inflammation' refers to the groups inoculated with P. gingiva/is). Data are means 
± SO (n=5 mice per group). **p < 0.01 compared to BSA-treated controls. 
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Fold change vs. 
Molecule Del-1-untreated controls 
CMC Pg 
IL-17 0.19 0.25 
TNF 0.50 0.51 
IL-6 0.25 0.24 
IL-1 0.50 0.25 
RANKL 0.49 0.25 
G-CSF 0.12 0.25 
CCL2 0.48 0.49 
CCL3 1.02 0.51 
CCL20 0.24 0.49 
CXCL 10 0.25 0.26 
CCR2 0.26 0.12 
CCR6 0.25 0.13 
CXCR4 0.50 0.24 
C3aR 0.49 0.49 
C5aR 0.50 0.25 
TREM-1 0.49 0.24 
TLR1 0.24 0.24 
TLR2 0.26 0.25 
TLR4 0.25 0.12 
TLR5 0.51 0.51 
TLR6 0.27 0.26 
TLR9 0.25 0.51 
C040 0.24 0.25 
C080 0.25 0.25 
C086 0.50 0.49 
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Table 2. Reduced mRNA levels of inflammatory mediators in the gingiva of 
aged mice after local administration of soluble Del-1. Eighteen-month-old 
C57BLl6 mice were microinjected with BSA (control) or Del-1 in the palatal 
gingiva between the first and the second molar teeth. The mice were then orally 
inoculated with 109 CFU Porphyromonas gingiva lis in 2% carboxymethylcellulose 
(CMC) or CMC only, and were sacrificed 12h later. The interdental gingiva (i.e., 
between first and second molar teeth) were dissected and processed for 
quantitative real-time PCR (qPCR) to determine gingival mRNA levels of the 
indicated molecules (normalized against GAPDH mRNA levels and expressed as 
fold change of Del-1-treated relative to corresponding BSA-treated controls). To 
ensure enough tissue material, dissected interdental gingiva from 5 mice per 
group were pooled before use in the qPCR. Consistent results were obtained 
from an identical independent experiment. 
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Del-1 expression is reduced in periodontitis patients. 
According to BLAST analysis, human and mouse Del-1 share 96% amino-
acid sequence identity, which readily explains why human Del-1 is functional in 
mice [90]. The purpose of these studies was to determine if the low Del-1 and 
high IL-17 expression seen in mouse periodontitis was relevant in human 
periodontitis. Tissues, which were harvested from healthy and diseased areas in 
the same subject, were stained for Del-1 expression. According to our 
preliminary data, Del-1 expression was dramatically reduced in diseased area as 
compared to healthy areas (Figure 22A). We next determined if IL-17 expression 
increased in diseased gingiva. We found, in contrast to reduced Del-1 
expression, that IL-17 expression was markedly increased in diseased areas 
(Figure 22B). Those results were consistent what we have found in old or Del-1 





Figure 23. Expression of IL-17 and Del-1 in human gingival. (a) Sagittal 
sections of human gingiva from healthy (a) or diseased (b) sites were stained for 




We showed here for the first time that Del-1 (a) serves a mechanism by 
which a tissue can control the local inflammatory response to prevent 
immunopathology and (b) may be a promising novel therapeutic for inflammatory 
diseases. Specifically, Del-1 is required for homeostatic inhibition of inflammatory 
periodontal bone loss involving LFA-1-dependent neutrophil recruitment and IL-
17R signaling. 
Importantly, Oel-r'- mice developed periodontitis naturally in a chronic 
setting of dysregulated neutrophil recruitment without requiring experimental 
intervention (e.g., superinfection with a human periodontal pathogen or injection 
of bone loss-inducing agents such as lipopolysaccharide) as is often required in 
animal periodontitis models [91]. A phenotype comparable to that of Oel-r'- mice 
was mirrored in wild type old mice, in which inflammatory bone loss increased 
linearly with reduced expression of Del-1. 
In turn, IL-17, which was expressed at higher levels in old age, negatively 
regulated Del-1 expression. This finding reveals a novel mechanism whereby IL-
17 orchestrates neutrophil recruitment. Previously, it was shown that IL-17 
promotes granulopoiesis and induces the chemotactic recruitment, activation, 
and survival of neutrophils [26-28]. Now we show that IL-17 also suppresses 
endogenous inhibitory mechanisms to facilitate the recruitment of neutrophils to 
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sites of infection. This function may be beneficial in the acute defense against 
infection, although- as shown here- it can become detrimental under chronic 
conditions. Persistent recruitment and infiltration of neutrophils into peripheral 
tissues may contribute to the pathogenesis of additional chronic inflammatory 
diseases, such as rheumatoid arthritis, inflammatory bowel disease, and chronic 
inflammatory lung diseases [12, 13, 42, 92]. Therefore, interventional approaches 
aiming to downregulate the recruitment or activation of neutrophils (e.g., Del-1 or 
anti-IL-17 biologics) may offer treatment solutions. 
The spontaneous disease phenotype of Oel-r/- mice suggests that the 
tissue may have greater control over the local host inflammatory response than 
the immune system itself. Del-1 acts locally in tissues that express it, such as the 
periodontium, by competing with LFA-1- dependent adhesion of neutrophils to 
endothelial ICAM-1 [52]. The restricted expression pattern of Del-1 likely confers 
its tissue-specific anti-inflammatory activity [43]. This role of Del-1 is in line with 
recent findings that growth differentiation factor-15, locally produced in the heart, 
protects the infarcted myocardium from excessive neutrophil infiltration by 
inhibiting integrin activation [14]. This recent study and our current findings 
support an emerging concept that tissues have evolved distinct local homeostatic 
mechanisms to control inflammatory cell recruitment and prevent tissue damage. 
To our knowledge, the abrogation of periodontitis in Oel-r/--IL-17R-1- mice 
represents the first time that IL-17R signaling is causally linked to periodontal 
bone loss, consistent with the elevated level of IL-17 in human periodontitis [4, 
93, 94]. Our findings are thus consistent with the elevated levels of IL-17 in 
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human periodontitis [4, 93-95] and in mouse periodontitis models [74, 96]. IL-17 
was also shown to stimulate antimicrobial immunity and thereby to inhibit 
pathogen-initiated bone loss in a relatively acute periodontitis model [97]; 
however, chronic IL-17R signaling can turn an acute inflammatory response into 
chronic immunopathology, as seen in rheumatoid arthritis [4, 22]. In this context, 
IL-17 can mediate connective tissue destruction and bone resorption efficiently 
and independently of IL-1 ~ and TNF-a; the underlying mechanisms are largely 
dependent on induction of matrix metalloproteases and RANKL (receptor 
activator of nuclear factor-KB ligand) [22, 98]. In this regard, the Oel-rl- mice 
exhibited 3-fold higher RANKL expression in the gingiva than wild-type controls, 
although both groups had similar expression of the RANKL inhibitor, 
osteoprotegerin (OPG) (Fig. 13). 
Furthermore, the recent demonstration that neutrophils express RANKL 
underscores their potential to directly engage in inflammatory bone destruction 
[99]. Although IL-17 is a signature cytokine of the CD4+ T-helper 17 subset, 
much of the IL-17 in inflammatory sites is actually contributed by innate immune 
sources [89]. Accordingly, we observed co localization of IL-17 and neutrophils in 
the gingiva. Neutrophils are thought to mediate periodontal tissue destruction 
through the release of inflammatory cytokines, oxygen radicals, and matrix-
degrading metalloproteases [19, 100]. The interplay between neutrophils and IL-
17 may generate a positive feedback loop of persistent neutrophil-mediated 
inflammation, which can be reversed, however, by local administration of Del-1, 
as indicated by its ability to inhibit IL-17 expression. This finding and our data that 
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the age-associated downregulation of Del-1 was mediated by IL-17 suggest a 
reciprocal cross-regulation of the two molecules. 
Dysregulated LFA-1-dependent recruitment is apparently the proximal 
cause for the increased neutrophil infiltration in the gingiva of Del-1-deficient 
mice. However, IL-17, the gingival expression of which was significantly elevated 
in genetic and age-associated Del-1 deficiency, could contribute to sustaining 
high neutrophil numbers. In this regard, IL-17 promotes granulopoiesis and 
orchestrates the recruitment, activation, and survival of neutrophils [26, 27]. 
Moreover, IL-23, which is a potent inducer of IL-17 production by both adaptive 
and innate immune sources [101, 102], was also upregulated (both IL-12/IL-
23p40 and IL-23p19 subunits were expressed at ==3-fold higher levels in Oe/-rl-
relative to wild-type mouse gingiva; Fig. 14a). Therefore, Del-1 deficiency causes 
enhanced neutrophil recruitment and IL-17 production, the interplay of which 
could generate a positive feedback loop of persistent neutrophil-mediated 
inflammation. 
Neutrophils are key effectors of periodontal tissue destruction through the 
release of inflammatory cytokines, oxygen radicals, and matrix-degrading 
metalloproteases [16, 87, 100]. The recent demonstration that neutrophils 
express RANKL underscores their potential to directly engage in inflammatory 
bone destruction [103, 104]. Although neutrophils play crucial roles in the acute 
defense against infection, their persistent recruitment and infiltration into tissues 
may contribute to the pathogenesis of additional chronic inflammatory diseases, 
such as rheumatoid arthritis, inflammatory bowel disease, and chronic 
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inflammatory lung diseases [12, 13, 42, 85, 86]. Therefore, interventional 
approaches aiming to downregulate the recruitment or activation of neutrophils 
(e.g., Del-1 or anti-IL-17 biologics) may offer treatment solutions. 
Since the proximal consequence of Del-1 deficiency is elevated LFA-1-
dependent neutrophil recruitment, the reason(s) for the increased oral microbial 
burden in Oe/-rl- mice is not obvious. It is possible that excessive cellular 
recruitment and inflammation creates an environment that impairs the neutrophil 
defensive functions, as seen in sepsis [105], leading to uncontrolled bacterial 
growth. Indeed, in sepsis, neutrophils can undergo 'immune paralysis', a 
condition largely dependent on C5aR signaling [105]. Interestingly, the 
expression of C5aR (and other receptors that amplify inflammation such as C3aR 
and TREM-1) was elevated in the absence of Del-1 (Fig. 13). Alternatively (or 
additionally), under inflammatory conditions, the gingival inflammatory exudate 
becomes a rich source of nutrients, such as hemin-derived iron and degraded 
host proteins, which would favor the growth of periodontal bacteria [88, 106]. The 
notion that inflammation contributes to bacterial growth is consistent with our 
observation that the high oral microbial burden associated with Del-1 deficiency 
was restored to near normal levels in Oe/-rl--LFA-rl- and Oe/-rl--IL-17R/- mice, 
which had reduced periodontal inflammation relative to Oe/-rl- mice. This positive 
reinforcement loop between inflammation and bacterial growth can perpetuate 
inflammatory tissue destruction, since increased levels of bacteria can in turn 
elicit even higher inflammation and bone loss. 
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The majority of the adult population experiences some form of periodontal 
disease and an estimated 10-15% develops severe periodontitis, which has 
significant economic consequences [107] and is a risk factor for systemic 
conditions [37, 76, 108, 109]. Moreover, old age is associated with increased 
prevalence and severity of periodontitis and a number of other chronic 
inflammatory diseases [2, 82, 84, 110]. The term 'inflamm-aging' was aptly 
coined to describe the heightened chronic inflammatory state often associated 
with old age in humans [111]. In this regard, the elderly show inappropriately high 
periodontal inflammatory responses relative to young individuals following 
comparable de novo biofilm formation [84]. A similar condition may apply to old 
mice which develop overt periodontitis [74]. From a mechanistic viewpoint, little 
is known regarding the impact of aging on innate immunity and inflammatory 
diseases [82, 84]. However, the reduced expression of Del-1 could be a major 
mechanism linking advanced age to destructive periodontal inflammation. 
Our findings support the feasibility of controlling the influx of neutrophils 
and ensuing inflammation through Del-1 treatment. Conventional periodontal 
treatment is often not sufficient by itself to control destructive inflammation and 
many patients develop recurrent disease [112]. Del-1 may thus offer a promising 
approach to treat periodontitis and reduce the risk for associated systemic 
diseases, whereas the anti-inflammatory properties of Del-1 may also find 
application in other inflammatory and autoimmune diseases [12, 42, 85, 86]. 
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5. CONCLUSION 
We showed that Del-1, a novel inhibitor of integrin-dependent neutrophil 
adhesion, regulates local tissue-specific inflammation and controls chronic 
inflammatory disease. Upon aging, normal mice developed periodontitis 
accompanied by diminished Del-1 expression. Consistent with a homeostatic role 
for Del-1, Del-1-1- mice developed spontaneous periodontitis featuring excessive 
local neutrophil infiltration and IL-17 expression. Disease was reversed in Del-1-1-
mice with additional deficiencies in the LFA-1 integrin or the IL-17 receptor. 
Intriguingly, Del-1 and IL-17 were reciprocally cross-regulated and the diminished 
expression of Del-1 in old age was associated with elevated IL-17 expression. 
The function of the immune system declines with age. It therefore follows 
that the complex cytokine network that orchestrates cell-cell interactions is also 
affected by age. Those age-associated changes in cytokine production have 
been investigated previously in both humans and rodents [113, 114]. For 
example, it has been shown that aging increased inflammation by inducing 
production of proinflammatory cytokines and chemokines such as IL-6 and 
CCL2, respectively [115]. It is well known that overproduction of IL-6 is 
associated with a spectrum of age-related conditions including cardiovascular 
disease, osteoporosis, arthritis, type 2 diabetes, certain cancers, and periodontal 
disease. Consistently, we have shown that the age-association of certain pro-
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inflammatory cytokines, including IL-1J3, TNF-a, IL-17A and IL-6, increased in the 
gingivae [74]. We also, in this study, found that reduction of inflammatory 
cytokines and chemokines production increased in Del-1 deficient mice. 
Together, it is clear that the host immune system is dysregulated by age. 
Homeostasis following periodontal injury is essential for the tissue 
regeneration or repair. Dysregulated homeostatis is associated with chronic 
inflammatory diseases, including rheumatoid arthritis, psoriasis, inflammatory 
bowel disease and periodontitis afflicting millions of people worldwide. 
Susceptibility to chronic disease is most likely genetically determined and 
immune response play a crucial role for the disease prognosis. Pro- or anti-
inflammatory cytokines induced locally modulate the course of the response 
whereby they can modulate the host response, which is the resistance or 
susceptibility to the particular pathogen. For example, it has been shown that IL-
4, IL-10, IL-13 and TGF-P., are some of key anti-inflammatory cytokines resulting 
tissue homeostasis in periodontium [17]. IL-4 contributes to negative immune 
regulation by reducing IL-2 receptor [116] or production of TNF-a, IL-1 and IL-6 in 
monocytes [117]. IL-10 has been show to reduce Th1 cell proliferation and 
cytokine production such as IFN-y [118]. IL-13 is other potent immune modulator 
and might contribute to the development of Th2 immune response by reducing 
IL-12 production [119]. Importantly, production of those anti-inflammatory 
cytokines, including IL-4, IL-10 and TGF-~, is reduced by age [114, 120]. 
All together, we think that increased inflammation by age due to 
dysregulated host immune responses to microorganisms could negatively affect 
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Del-1 expression. Indeed, we observed that inflammation resulted in reduced 
expression of Del-1 in our ligature-induced periodontitis model and it also is 
reported that Del-1 expression was regulated inflamed tissue and the endothelial 
cell upon stimulated by TNF-a [52]. 
Another possible mechanism that could explain why we see more 
inflammatory response in old mice might be changes in neutrophils' function 
seen in the elderly [121]. Neutrophils are an important part of the immune 
response towards invading organisms. They are the first line of defense, forming 
part of the innate immune response. With aging, decreases have been recently 
demonstrated in specific cell functions, such as apoptosis/survival of PMN [121]. 
These alterations might contribute to the increased incidence of infections with 
aging. Apoptosis plays an important role in the regulation of tissue development, 
differentiation and homeostasis as well as in several pathologies in chronic 
inflammatory diseases [122, 123]. Mature neutrophils undergo spontaneous 
apoptosis very rapidly when maintained in vitro; this sensitivity to apoptosis 
regulates both their production and their survival. However, their lifespan has 
been reported to be reduced by age [124], leading to the increased number of 
apoptotic cells in the inflamed area. To sustain homeostasis, these apoptotic 
neutrophils are quickly removed by professional phagocytes such as 
macrophages [125]. The engulfment of apoptotic cells provides a benefit to the 
host by preventing the inflammation and tissue damage that can be caused by 
intracellular materials being released from dying cells. Thus, it is expected to 
have more inflammation upon the burden of apoptotic cells exceeds the capacity 
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of the macrophages. Importantly, Del-1 has been reported to bind specifically 
apoptotic cells by recognizing phosphatidylserine [72]. In this study, it was clearly 
shown that Del-1 can work as a bridge between apoptotic cells and phagocytes 
[72]. Since macrophages are a key player to clean up apoptotic cells, it can be 
questioned the number macrophage in the elderly or Del-1 deficient mice. It has 
been reported that macrophage function, rather than their number, is affected by 
age [126]. We also found showed that CD14 expression showed a similar 
expression level in Del-1 deficient or wild type mice (data not shown). Together, 
reduced engulfment of apoptotic neutrophils by macrophages could lead to 
increased inflammation seen in the elderly. 
We demonstrated that Del-1 is required for homeostatic inhibition of 
inflammatory periodontal bone loss involving LFA-1-dependent neutrophil 
recruitment and IL-17R signaling. In Del-1-1- mice, periodontitis developed 
spontaneously in a chronic setting of dysregulated neutrophil recruitment without 
requiring experimental intervention (e.g., superinfection with a human periodontal 
pathogen or injection of bone loss-inducing agents such as lipopolysaccharide) 
as often required in animal periodontitis models [91]. A phenotype comparable to 
that of Del-1-1- mice was mirrored in normal old mice, in which inflammatory bone 
loss increased linearly with reduced expression of Del-1. 
We found that the periodontal bone loss associated with Del-1 defiCiency 
was drastically (>75%) reversed in Oel-rl--LFA-rl- mice, which additionally 
displayed reduced neutrophil infiltration in the gingiva as compared to Oel-rl-
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mice. Therefore, the protective role of Oel-1 against periodontitis is mediated 
through regulation of LFA-1-dependent neutrophil trafficking. 
Moreover, in comparison to Oe/-rl- mice, the Oe/-rl--LFA-rl- mice 
displayed decreased gingival levels of IL-17 due to, at least in part, reduced 
infiltration of neutrophils, which expressed IL-17. In this regard, we observed 
co localization of IL-17 and Ly6G in gingival tissues of both Oel-rl- and Oel-rl--
LFA-rl-mice by immunohistochemistry. This observation is consistent with the 
notion that much of the IL-17 released at sites of inflammation derives from 
innate immune cells, including neutrophils [89]. 
The development of periodontitis was abrogated in Oel-1-1--IL-17R-1- mice 
and this, to our knowledge, is the first time that IL-17R signaling is causally linked 
to alveolar bone loss. Our findings are thus consistent with the elevated levels of 
IL-17 in human periodontitis [4, 93-95] and in mouse periodontitis models [74, 
96]. IL-17 was also shown to stimulate antimicrobial immunity and thereby to 
inhibit pathogen-initiated bone loss in a relatively acute periodontitis model [97]; 
however, chronic IL-17R signaling can turn an acute inflammatory response into 
chronic immunopathology, as seen in rheumatoid arthritis [4, 22]. In this context, 
IL-17 can mediate connective tissue destruction and bone resorption efficiently 
and independently of IL-1 J3 and TNF-a; the underlying mechanisms are largely 
dependent on induction of matrix metalloproteases and RANKL (receptor 
activator of nuclear factor-KB ligand) [22, 98]. In this regard, the Oel-r/- mice 
exhibited 3-fold higher RANKL expression in the gingiva than wild-type controls, 
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although both groups had similar expression of the RANKL inhibitor, 
osteoprotegerin. 
These findings indicate that Del-1 deficiency causes periodontal bone loss 
that is dependent on LFA-1-dependent neutrophil recruitment and IL-17R 
signaling. Moreover, conditions that restore tissue homeostasis in terms of 
periodontal bone maintenance (i.e., dual Del-1/LFA-1 or Del-1I1L-17R 
deficiencies) also reverse the numbers of oral bacteria to near normal levels. 
Importantly, age-associated periodontal inflammation (including neutrophil 
accumulation and IL-17 production) was suppressed by local administration of 
Del-1. Del-1 is associated with the extracellular matrix and endothelial cell 
surface but not circulated in the blood [127]. It has recently shown that Del-1 is 
expressed in tissue specific-manner: very little expression in the kidney, none in 
the liver and a strong expression in the eye and brain [52], suggesting that Del-1 
might be a key player in a certain tissues that may face unspecified immune 
response. Del-1 structure consists of five domains: repeat domains (E1, E2 and 
E3), three epidermal growth factors (EGF) at its N-terminus and two discoidin 
domains at its C-terminus. E2 contains RGD sequence (Arg-Gly-Asp), which 
binds integrin avj33 or a5j33 (Figure 24) [128]. The discoidin domains have been 
shown to be responsible for binding phosphatidyl serine-rich membranes. 
However, EGF like repeats have been shown to enable Del-1 to bind integrin 
[128]. Unlike many adhesion molecules, Del-1 inhibits the process of neutrophils 
binding to endothelial cells, thereby blocking entrance of neutrophils into inflamed 
tissues. Under normal flow physiologic conditions, addition of Del-1 to the system 
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where neutrophils adhere onto immobilized ICAM-1 with activated LFA-1 
suppresses the binding of neutrophils [52]. This finding implies that Del-1 may 
compete with ICAM-1 for the binding to LFA-1. All together, modulation of Del-1 
expression could be a candidate therapeutic strategy for autoimmune and 
chronic inflammatory disease. However, the usage of Del-1 clinically would be so 
costly thereby it could not be afforded. Alternatively, some companies tried to 
make synthetic inhibitors or antibodies to inhibit ICAM-1/LFA-1 binding. The 
ICAM-1/LFA-1 interaction can be controlled at the site of LFA-1/ICAM interaction, 
the metal-ion-dependent adhesion site (MIDAS), or through binding to an 
allosteric site on LFA-1 [129] that causes it to adopt a conformation that cannot 
bind to ICAM-1 . For example, the LFA inhibitor (LFA878), which binds an 
allosteric site on LFA-1, has been shown to inhibit the interaction between ICAM-
1 and LFA-1 [130]. Therefore, we used the LFA-1 inhibitor (LFA878) or Del-1 to 
prevent alveolar bone resorption and found Del-1 was more protective than that 
of LFA878 (data not shown). Our findings could be explained by the fact that 
LFA878 is not a competitive inhibitor, unlike Del-1, its half-life is not long enough 
to block the ICAM-1/LFA-1 interaction or it obviously doesn't function as much as 
Del-1 does at the cellular level. It is highly possible that Del-1 could have 
activities that remain undiscovered. Since it contains EGF domain (Figure 24), it 
can induce a number of signaling that needs to be studied. Indeed, Del-1 has 
recently shown to induce apoptosis through its EGF domains [131]. It is, 
therefore, obvious that all synthetic inhibitors or antibodies, which are available 
commercially, will not function like Del-1 functions. 
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--. egf-t - egf-2 - egf-3 
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Immune Netw. 2009 Oct;9(5) :153-7. Epub 2009 Oct 30. 
Figure 24. Showing a domain structure of Del-1 . Del-1 structure consists of five 
domains: repeat domains (E1 , E2 and E3) , three epidermal growth factors (EGF) 
at its N-terminus and two discoidin domains at its C-terminus. E2 contains RGD 
sequence (Arg-Gly-Asp) , which binds integrin av~3 or a5~3 . 
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Finally, our preliminary human results showed that Del-1 expression was 
dramatically reduced in diseased area as compared to healthy areas. We also 
found, in contrast to reduced De-1 expression, that IL-17 expression was 
markedly increased in diseased areas. Those results were completely consistent 
what we have found in old or Del-1 deficient mice. Del-1 could be associated with 
a spectrum of age-associated diseases whose onset and course may be 
influenced by pro-inflammatory cytokines. The finding that reduced Del-1 
expression in old mice is capable of substantially augmenting bone loss. These 
data provide important evidence of one of key mechanisms through which 
reduced Del-1 expression may have potent health consequences for older adults, 
accelerating risk of a host of age-related diseases. 
Overall, the main conclusions could be summarized as follows: 
• Del-1 is a homeostatic regulator of chronic tissue inflammation involving 





Del-1 expression is diminished in old age leading to periodontal 
inflammation and bone loss. 
Local administration of Del-1 reverses periodontal inflammation and may 
thus be a promising novel therapeutic for the treatment of periodontitis. 
Our preliminary human data showed that Del-1 expression was higher in 
healthy gingivae than diseased sites. In contrast, IL-17 expression was lower 
in healthy sites than disease sites. 
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Together, Del-1 inhibits LFA-1-dependent neutrophil recruitment and IL-
17 -mediated pathology and may be a promising novel therapeutic for trating 
diseases related to excessive or deficient recruitment of neutrophils. If 
excessive recruitment is desired (infectious disease), a strategy to block Del-1 
should be taken. In contrast, if excessive neutrohil is the issue, a strategy to 
boost Del-1 should be taken. 
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